CLASS II ONGOING Drug recall · Reported 3 Sep 2025 · FDA Enforcement Report

Acetaminophen Injection 1000 mg/ (10 mg/mL) recalled

Baxter Healthcare is recalling Acetaminophen Injection 1000 mg/ (10 mg/mL), distributed nationwide in the US. The recall was initiated on 20 Aug 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 24A27G66, Exp 12/31/2025
NDC36000-306, 36000-372
Quantity recalled13,000 containers

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0596-2025
FDA event ID
97453
Recalling firm
Baxter Healthcare, Deerfield, IL
Manufacturer
Baxter Healthcare Corporation
Classification
Class II
Status
Ongoing
Recall initiated
20 Aug 2025
FDA classified
22 Aug 2025
Reported
3 Sep 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects
Drug class
Pain Medication

Timeline

20 Aug 2025Recall initiated by company
22 Aug 2025Classified by FDA+2 days
3 Sep 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Discoloration

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Acetaminophen Injection 1000 mg/100 mL (10 mg/mL), packaged in 100 mL Viaflo container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in Ireland, NDC 36000-306-60.

Where it was distributed

U.S.A. Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Discoloration

Which lots are affected?

Lot #: 24A27G66, Exp 12/31/2025

Where was it sold?

U.S.A. Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Baxter Healthcare

All 577

Other Acetaminophen recalls

All 61